News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
Presentation ESC 2016 Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial Presenter: Raban V. Jeger August 31, 2016
News Conference News ESC 2016 BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use Shelley Wood August 31, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Conference News EuroPCR 2016 Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events Shelley Wood May 18, 2016
News Features From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing Todd Neale November 08, 2015
News Daily News Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients Jason Kahn October 11, 2013
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES L.A. McKeown June 10, 2011
News Conference News ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions Jason Kahn April 04, 2011
News Daily News Vascular Stents an Option for Some Patients with Fibrosing Mediastinitis March 29, 2011
News Daily News Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease Jason Kahn January 23, 2011